Navisha Dookie

681 total citations · 1 hit paper
13 papers, 409 citations indexed

About

Navisha Dookie is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Navisha Dookie has authored 13 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Navisha Dookie's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Navisha Dookie is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (8 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Navisha Dookie collaborates with scholars based in South Africa and United States. Navisha Dookie's co-authors include Kogieleum Naidoo, Nesri Padayatchi, Santhuri Rambaran, Sharana Mahomed, Prashini Moodley, Rubeshan Perumal, Adriaan Willem Sturm, A. Willem Sturm, Nonhlanhla Yende‐Zuma and Halima Dawood and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Navisha Dookie

13 papers receiving 400 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care

2018 222 citations Navisha Dookie, Santhuri Rambaran et al. Journal of Antimicrobial Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Navisha Dookie South Africa	9	316	249	110	102	31	13	409
Santhuri Rambaran South Africa	6	207 0.7×	164 0.7×	84 0.8×	62 0.6×	25 0.8×	11	294
Julian González-Martín Spain	14	326 1.0×	331 1.3×	113 1.0×	137 1.3×	41 1.3×	33	565
Elizabeth J. Brooks United States	11	343 1.1×	270 1.1×	129 1.2×	75 0.7×	34 1.1×	11	526
Lidya Chaidir Indonesia	12	303 1.0×	217 0.9×	75 0.7×	231 2.3×	17 0.5×	41	465
Juan Ignacio García United States	9	222 0.7×	146 0.6×	103 0.9×	57 0.6×	22 0.7×	20	302
Afton Dorasamy South Africa	8	258 0.8×	251 1.0×	51 0.5×	57 0.6×	29 0.9×	9	332
Chivonne Moodley United States	9	212 0.7×	174 0.7×	86 0.8×	48 0.5×	25 0.8×	14	343
Rosemary V. Swanson United States	7	205 0.6×	180 0.7×	82 0.7×	40 0.4×	34 1.1×	15	345
Christopher A. Kerantzas United States	5	218 0.7×	170 0.7×	89 0.8×	43 0.4×	74 2.4×	7	327
Mariama C. Maiga United States	9	280 0.9×	168 0.7×	169 1.5×	50 0.5×	62 2.0×	10	384

Countries citing papers authored by Navisha Dookie

Since Specialization

Citations

This map shows the geographic impact of Navisha Dookie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navisha Dookie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navisha Dookie more than expected).

Fields of papers citing papers by Navisha Dookie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navisha Dookie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navisha Dookie. The network helps show where Navisha Dookie may publish in the future.

Co-authorship network of co-authors of Navisha Dookie

This figure shows the co-authorship network connecting the top 25 collaborators of Navisha Dookie. A scholar is included among the top collaborators of Navisha Dookie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navisha Dookie. Navisha Dookie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Dookie, Navisha, et al.. (2023). Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 33. 100387–100387. 4 indexed citations

Perumal, Rubeshan, et al.. (2023). Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment. Infection and Drug Resistance. Volume 16. 2849–2859. 4 indexed citations

Dookie, Navisha, et al.. (2022). Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field. Frontiers in Microbiology. 13. 775030–775030. 43 indexed citations

Naidoo, Kogieleum & Navisha Dookie. (2022). Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing?. The Lancet Infectious Diseases. 22(4). e121–e127. 20 indexed citations

Naidoo, Kogieleum, Razia Hassan-Moosa, Navisha Dookie, et al.. (2022). Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes. Clinical Infectious Diseases. 75(9). 1628–1636. 11 indexed citations

Dookie, Navisha, et al.. (2022). The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives. Clinical Microbiology Reviews. 35(4). e0018019–e0018019. 40 indexed citations

Dookie, Navisha, et al.. (2020). Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing. Clinical Infectious Diseases. 71(11). 2981–2985. 4 indexed citations

Naidoo, Kogieleum, Navisha Dookie, Kogieleum Naidoo, et al.. (2018). Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal. Infection and Drug Resistance. Volume 11. 1413–1421. 9 indexed citations

Dookie, Navisha, Santhuri Rambaran, Nesri Padayatchi, Sharana Mahomed, & Kogieleum Naidoo. (2018). Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. Journal of Antimicrobial Chemotherapy. 73(5). 1138–1151. 222 indexed citations breakdown →

10.

Rambaran, Santhuri, et al.. (2018). Resistance Profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa Questioning the Effect of the Currently Advocated Dual Therapy. Sexually Transmitted Diseases. 46(4). 266–270. 24 indexed citations

11.

Mahomed, Sharana, Kogieleum Naidoo, Navisha Dookie, & Nesri Padayatchi. (2017). Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications. Tuberculosis. 107. 137–143. 13 indexed citations

12.

Dookie, Navisha, A. Willem Sturm, & Prashini Moodley. (2016). Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. BMC Infectious Diseases. 16(1). 609–609. 10 indexed citations

13.

Moodley, Prashini, A. Willem Sturm, & Navisha Dookie. (2014). Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis. Infection and Drug Resistance. 7. 223–223. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact